Immune Privilege Within: Regulatory T Cells Tip the Balance in Favor of Lymph Node Metastasis

Cancer Discov. 2025 Sep 4;15(9):1780-1782. doi: 10.1158/2159-8290.CD-25-1043.

Abstract

Kahn and colleagues reveal that lymph nodes (LN) provide an intrinsically immunosuppressive niche that prevents effector function of activated CD8+ T cells in LNs and allows immunogenic tumor cells to survive and drive cancer progression, independent of tumor-derived preconditioning. By locally suppressing IL2 availability, regulatory T cells in LNs impair CD8+ T-cell cytotoxicity-a mechanism with important implications for immune checkpoint therapy and LN-targeted immunomodulation. See related article by Kahn et al., p. 1949.

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / immunology
  • Humans
  • Lymph Nodes / immunology
  • Lymph Nodes / pathology
  • Lymphatic Metastasis* / immunology
  • Neoplasms* / immunology
  • Neoplasms* / pathology
  • T-Lymphocytes, Regulatory* / immunology